Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.

MLA

Bramuzzo, Matteo, et al. “Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.” Inflammatory Bowel Diseases, vol. 30, no. 1, Jan. 2024, pp. 20–28. EBSCOhost, https://doi.org/10.1093/ibd/izad018.

APA

Bramuzzo, M., Giudici, F., Arrigo, S., Lionetti, P., Zuin, G., Romano, C., Graziano, F., Faraci, S., Alvisi, P., Signa, S., Scarallo, L., Martelossi, S., & Leo, G. D. (2024). Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease. Inflammatory Bowel Diseases, 30(1), 20–28. https://doi.org/10.1093/ibd/izad018

Chicago

Bramuzzo, Matteo, Fabiola Giudici, Serena Arrigo, Paolo Lionetti, Giovanna Zuin, Claudio Romano, Francesco Graziano, et al. 2024. “Efficacy and Tolerance of Thalidomide in Patients With Very Early Onset Inflammatory Bowel Disease.” Inflammatory Bowel Diseases 30 (1): 20–28. doi:10.1093/ibd/izad018.